FET Clinical Trials in Los Angeles, California
6 recruitingLos Angeles, California
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC120 enrolled61 locationsNCT05912517
Recruiting
Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
AVB - Atrioventricular BlockFetal AVB
NYU Langone Health1,300 enrolled24 locationsNCT04474223
Recruiting
Not Applicable
A Trial to Improve Family Clinical Note Access and Outcomes for Hospitalized Children
Hospitalized ChildPediatric Patient SafetyMedical Errors+2 more
University of Wisconsin, Madison630 enrolled3 locationsNCT06722378
Recruiting
Phase 3
CAR-T Long Term Follow Up (LTFU) Study
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals1,400 enrolled118 locationsNCT02445222
Recruiting
Not Applicable
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
Attention Deficit Hyperactivity DisorderFetal Alcohol Spectrum Disorders
University of California, Los Angeles30 enrolled1 locationNCT06847165
Recruiting
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
Down SyndromeFetal Aneuploidy
Sequenom, Inc.2,000 enrolled14 locationsNCT01429389